Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MDM4 | O15151 | 2/20 | 0.54 |
| ▸ | TP53 | P04637 | 2/20 | 0.54 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.51 |
| ▸ | MDM2 | Q00987 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26160451 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29446045 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29356265 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29401309 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29564442 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL119043 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29349978 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL178736 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29508222 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 | |
| SCHEMBL29446029 | 1.00 | CASP3 (0.57) | CASP3KMT2AMDM4TP53EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 718 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119591674-A | Cyclohexapeptide and preparation method and application thereof | 陕西未来多肽生物科技有限公司 | 2025-03-11 | — | — | CN | claimed |
| WO-2024017317-A1 | HER2 TARGETING PEPTIDE MOLECULE AND USE THEREOF | 中国科学院上海药物研究所 | 2024-01-25 | — | — | WO | claimed |
| CN-117430670-A | HER2 targeting peptide molecule and application thereof | 中国科学院上海药物研究所 | 2024-01-23 | — | — | CN | claimed |
| CN-116789731-A | Preparation method of short peptide Fmoc-L-Ala-L-Ala-OH | 成都郑源生化科技有限公司 | 2023-09-22 | — | — | CN | claimed |
| US-20230242572-A1 | a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | JIANGXI NORMAL UNIVERSITY (CN) | 2023-08-03 | — | — | US | claimed |
| CN-109824622-B | Prodrug forming nano structure in cell to kill cancer cell and its prepn | 中国科学技术大学 | 2022-12-30 | — | — | CN | claimed |
| US-20220289811-A1 | A FORMULATION OF INSULIN BASED ON CRYSTAL-SEEDING IN HYDROGELS AND METHOD THEREOF | LAMARK BIOTECH PVT LTD (IN) | 2022-09-15 | — | — | US | claimed |
| CN-113072620-B | PD-1 targeting peptide with analgesic activity, and synthesis method and application thereof | 南通大学 | 2022-07-05 | — | — | CN | claimed |
| EP-4013778-A1 | A FORMULATION OF INSULIN BASED ON CRYSTAL-SEEDING IN HYDROGELS AND METHOD THEREOF | Lamark Biotech PVT Limited (IN) | 2022-06-22 | — | — | EP | claimed |
| CN-113527416-A | Preparation method of nitroreductase responsive amino acid and tumor hypoxia fluorescent probe | 南开大学 | 2021-10-22 | — | — | CN | claimed |
| WO-2021033066-A1 | A FORMULATION OF INSULIN BASED ON CRYSTAL-SEEDING IN HYDROGELS AND METHOD THEREOF | LAMARK BIOTECH PVT LIMITED (IN) | 2021-02-25 | — | — | WO | claimed |
| CN-112159461-A | Synthesis method of cetrorelix | 开封明仁药业有限公司 | 2021-01-01 | — | — | CN | claimed |
| CN-112110834-A | Modified hydrophobic auxiliary material and preparation method and application thereof | 浙江智达药业有限公司 | 2020-12-22 | — | — | CN | claimed |
| CN-101224306-B | Folic acid-polypeptide compound-mediated targeting anti-tumor prodrug and preparing method thereof | UNIV SUN YAT SEN | 2011-04-20 | — | — | CN | claimed |
| EP-1685134-B1 | NOVEL CHELIDONINE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, AND USE THEREOF FOR PRODUCING PHARMACEUTICAL AGENTS | SALAMA ZOSER B NAT RER DR (DE) | 2009-02-11 | — | — | EP | claimed |
| US-20080039483-A1 | Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents | SALAMA ZOSER B | 2008-02-14 | — | — | US | claimed |
| EP-1212348-A2 | PURIFICATION AND ANALYSIS OF CYCLIC PEPTIDE LIBRARIES, AND COMPOSITIONS THEREOF | Consensus Pharmaceuticals, Inc. (US) | 2002-06-12 | — | — | EP | claimed |
| US-20020019061-A1 | PURIFICATION AND ANALYSIS OF CYCLIC PEPTIDE LIBRARIES, AND COMPOSITIONS THEREOF | IWA, LLC | 2002-02-14 | — | — | US | claimed |
| WO-2001016160-A2 | PURIFICATION AND ANALYSIS OF CYCLIC PEPTIDE LIBRARIES, AND COMPOSITIONS THEREOF | CONSENSUS PHARMACEUTICALS, INC. (US) | 2001-03-08 | — | — | WO | claimed |
| EP-0357750-B1 | URETHANE-PROTECTED AMINO ACID-N-CARBOXYANHYDRIDES | BIORESEARCH INC (US) | 1994-07-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039483-A1 | Novel Chelidonine Derivatives, Methods for the Production Thereof, and Use Thereof For Producing Pharmaceutical Agents | KIT, MKI67, MCL1 | CASP3 314/4885KMT2A 1448/4885MDM4 3248/4885 |
| US-20230242572-A1 | a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | ACSL1, ACSL4, WEE1 | CASP3 3706/4885KMT2A 3061/4885MDM4 3883/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.